We appreciate that IFN-I signaling could be due to MYD88 signaling resulting from epigenetic re-expression of retroviral elements or from the response to genetic material from dying cells (58), and operates as a bridge between innate and adaptive anti-tumor immunity. This evidence concerns the gene MYD88 and neoplasm.